Business

Breaking information: DGCI approves emergency use of Zydus Cadila’s Virafin for average COVID-19 an infection


Medicine Controller Normal of India, DGCI, on Friday (April 23) permitted the emergency use for Zydus Cadila’s Pegylated Interferon alpha-2b, ‘Virafin’ for treating average COVID-19 an infection in adults.





Supply hyperlink